Showing 29,801 - 29,820 results of 46,288 for search '(( 5 ((step decrease) OR (mean decrease)) ) OR ( 50 ((we decrease) OR (a decrease)) ))', query time: 0.82s Refine Results
  1. 29801
  2. 29802
  3. 29803

    Excitation-Contraction Coupling in Zebrafish Ventricular Myocardium Is Regulated by Trans-Sarcolemmal Ca<sup>2+</sup> Influx and Sarcoplasmic Reticulum Ca<sup>2+</sup> Release by Moritz Haustein (734263)

    Published 2015
    “…Surprisingly though, inhibition of the sarcoplasmic Ca<sup>2+</sup>-release decreased force development to 54±3% in ventricular (n=13, p<0.05) and to 52±8% in atrial myocardium (n=5, p<0.05) suggesting a substantial role of SR Ca<sup>2+</sup>-release in force generation. …”
  4. 29804

    (A): Orexin A inhibits propofol-induced neurite retraction by activation of phospholipase D. by Karin Björnström (118598)

    Published 2014
    “…OA increases the PKCε Ser<sup>729</sup> phosphorylation compared to CCM, and this is reduced when PLD is blocked by FIPI, whereas propofol-treated cells showed a decrease in PKCε Ser<sup>729</sup> phosphorylation that increased after FIPI treatment (n = 5). …”
  5. 29805

    Table1_Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Suppress... by Fei-lin Ge (11611192)

    Published 2021
    “…The inhibition rates of LWWL (0.8 mg/ml) on HBV DNA, HBsAg, and pgRNA were 57.06, 38.55, and 62.49% in HepG2.2.15 cells, and 51.57, 17.57, and 53.88% in HepG2. A64 cells, respectively. LWWL (2 g kg<sup>−1</sup> d<sup>−1</sup> for 4 weeks)-treated mice had 1.16 log<sub>10</sub> IU/mL decrease of serum HBV DNA, and more than 50% decrease of serum HBsAg/HBeAg and hepatic HBsAg/HBcAg. …”
  6. 29806

    DataSheet3_Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Supp... by Fei-lin Ge (11611192)

    Published 2021
    “…The inhibition rates of LWWL (0.8 mg/ml) on HBV DNA, HBsAg, and pgRNA were 57.06, 38.55, and 62.49% in HepG2.2.15 cells, and 51.57, 17.57, and 53.88% in HepG2. A64 cells, respectively. LWWL (2 g kg<sup>−1</sup> d<sup>−1</sup> for 4 weeks)-treated mice had 1.16 log<sub>10</sub> IU/mL decrease of serum HBV DNA, and more than 50% decrease of serum HBsAg/HBeAg and hepatic HBsAg/HBcAg. …”
  7. 29807

    DataSheet4_Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Supp... by Fei-lin Ge (11611192)

    Published 2021
    “…The inhibition rates of LWWL (0.8 mg/ml) on HBV DNA, HBsAg, and pgRNA were 57.06, 38.55, and 62.49% in HepG2.2.15 cells, and 51.57, 17.57, and 53.88% in HepG2. A64 cells, respectively. LWWL (2 g kg<sup>−1</sup> d<sup>−1</sup> for 4 weeks)-treated mice had 1.16 log<sub>10</sub> IU/mL decrease of serum HBV DNA, and more than 50% decrease of serum HBsAg/HBeAg and hepatic HBsAg/HBcAg. …”
  8. 29808

    DataSheet1_Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Supp... by Fei-lin Ge (11611192)

    Published 2021
    “…The inhibition rates of LWWL (0.8 mg/ml) on HBV DNA, HBsAg, and pgRNA were 57.06, 38.55, and 62.49% in HepG2.2.15 cells, and 51.57, 17.57, and 53.88% in HepG2. A64 cells, respectively. LWWL (2 g kg<sup>−1</sup> d<sup>−1</sup> for 4 weeks)-treated mice had 1.16 log<sub>10</sub> IU/mL decrease of serum HBV DNA, and more than 50% decrease of serum HBsAg/HBeAg and hepatic HBsAg/HBcAg. …”
  9. 29809

    DataSheet6_Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Supp... by Fei-lin Ge (11611192)

    Published 2021
    “…The inhibition rates of LWWL (0.8 mg/ml) on HBV DNA, HBsAg, and pgRNA were 57.06, 38.55, and 62.49% in HepG2.2.15 cells, and 51.57, 17.57, and 53.88% in HepG2. A64 cells, respectively. LWWL (2 g kg<sup>−1</sup> d<sup>−1</sup> for 4 weeks)-treated mice had 1.16 log<sub>10</sub> IU/mL decrease of serum HBV DNA, and more than 50% decrease of serum HBsAg/HBeAg and hepatic HBsAg/HBcAg. …”
  10. 29810

    DataSheet5_Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Supp... by Fei-lin Ge (11611192)

    Published 2021
    “…The inhibition rates of LWWL (0.8 mg/ml) on HBV DNA, HBsAg, and pgRNA were 57.06, 38.55, and 62.49% in HepG2.2.15 cells, and 51.57, 17.57, and 53.88% in HepG2. A64 cells, respectively. LWWL (2 g kg<sup>−1</sup> d<sup>−1</sup> for 4 weeks)-treated mice had 1.16 log<sub>10</sub> IU/mL decrease of serum HBV DNA, and more than 50% decrease of serum HBsAg/HBeAg and hepatic HBsAg/HBcAg. …”
  11. 29811

    DataSheet2_Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Supp... by Fei-lin Ge (11611192)

    Published 2021
    “…The inhibition rates of LWWL (0.8 mg/ml) on HBV DNA, HBsAg, and pgRNA were 57.06, 38.55, and 62.49% in HepG2.2.15 cells, and 51.57, 17.57, and 53.88% in HepG2. A64 cells, respectively. LWWL (2 g kg<sup>−1</sup> d<sup>−1</sup> for 4 weeks)-treated mice had 1.16 log<sub>10</sub> IU/mL decrease of serum HBV DNA, and more than 50% decrease of serum HBsAg/HBeAg and hepatic HBsAg/HBcAg. …”
  12. 29812

    DataSheet7_Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Supp... by Fei-lin Ge (11611192)

    Published 2021
    “…The inhibition rates of LWWL (0.8 mg/ml) on HBV DNA, HBsAg, and pgRNA were 57.06, 38.55, and 62.49% in HepG2.2.15 cells, and 51.57, 17.57, and 53.88% in HepG2. A64 cells, respectively. LWWL (2 g kg<sup>−1</sup> d<sup>−1</sup> for 4 weeks)-treated mice had 1.16 log<sub>10</sub> IU/mL decrease of serum HBV DNA, and more than 50% decrease of serum HBsAg/HBeAg and hepatic HBsAg/HBcAg. …”
  13. 29813

    Supplemental data of Glucocorticoid Dependent Mesenchymal Cell Differentiation is Required for Perinatal Lung Morphogenesis and Lung Function by Yan Xu (6655778)

    Published 2020
    “…Red and green nodes represent ligands increased or decreased in mesenchymal GR deletion lung (Col1a2Cre;Nr3c1<sup>fl/fl</sup>) at E18.5, respectively. …”
  14. 29814

    Polymerase chain reaction mixtures and amplification conditions. by Henk Bolhuis (62487)

    Published 2013
    “…</p>3<p>A final extension of 30 minutes at 95°C was applied in order to prevent band duplication according to <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0063166#pone.0063166-Janse1" target="_blank">[53]</a>.</p>4<p>en step touch down with annealing temperature decreasing −0.5°C per cycle.…”
  15. 29815

    National Land Cover Database (NLCD) Tree Canopy Cover (TCC) Southeast Alaska by U.S. Forest Service (17476914)

    Published 2025
    “…For information on the Science data and processing steps see the Science metadata. Information on the NLCD data and processing steps are included here. …”
  16. 29816
  17. 29817
  18. 29818
  19. 29819
  20. 29820